Vestor Capital’s iShares Biotechnology ETF IBB Stock Holding History

Vestor Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-380	Closed	-$58K	–	236
2021 Q4	$58K	Hold	380	–	–	0.01%	199
2021 Q3	$61K	Hold	380	–	–	0.01%	188
2021 Q2	$62K	Hold	380	–	–	0.01%	176
2021 Q1	$57K	Hold	380	–	–	0.01%	181
2020 Q4	$58K	Hold	380	–	–	0.01%	164
2020 Q3	$51K	Buy	+380	New	+$51.6K	0.01%	124
2020 Q1	$41K	Hold	380	–	–	0.01%	135
2019 Q4	$46K	Sell	380 -35	-8%	-$3.9K	0.01%	148
2019 Q3	$41K	Hold	415	–	–	0.01%	136
2019 Q2	$45K	Sell	415 -49,591	-99%	-$5.27M	0.01%	123
2019 Q1	$5.59M	Buy	50,006 +1,604	+3%	+$176K	1.02%	38
2018 Q4	$4.67M	Buy	48,402 +225	+0.5%	+$23.9K	1.02%	36
2018 Q3	$5.88M	Sell	48,177 -270	-0.6%	-$31.8K	1.14%	33
2018 Q2	$5.32M	Buy	48,447 +20,985	+76%	+$2.24M	1.08%	37
2018 Q1	$2.93M	Buy	27,462 +957	+4%	+$106K	0.61%	49
2017 Q4	$2.83M	Buy	+26,505	New	+$2.83M	0.61%	50
2016 Q1	–	Sell	-624	Closed	-$70K	–	97
2015 Q4	$70K	Hold	624	–	–	0.02%	84
2015 Q3	$63K	Hold	624	–	–	0.02%	87
2015 Q2	$77K	Hold	624	–	–	0.02%	85
2015 Q1	$71K	Hold	624	–	–	0.02%	82
2014 Q4	$63K	Buy	+624	New	+$60.6K	0.02%	94

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vestor Capital's IBB Position: Q1 2022 in Review

Vestor Capital sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 380 shares — an estimated $58K sold.

Vestor Capital first reported a position in IBB in Q4 2014 and held it in 21 quarters. The position peaked at $5.88M in Q3 2018. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Vestor Capital reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Vestor Capital sold 380 iShares Biotechnology ETF shares in Q1 2022, an estimated $58K.
Vestor Capital first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 21 quarters.
Vestor Capital's iShares Biotechnology ETF position peaked at $5.88M in Q3 2018.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Vestor Capital's 13F filing for Q1 2022, filed 9 May 2022.